ACC 2019: Disparities persist in treatment of symptomatic aortic valve stenosis
New research shows that although racial disparities have diminished in recent years, gender disparities are still common.
ACC 2019: Oral anticoagulants underused, aspirin overused to treat atrial fibrillation in patients with advanced chronic kidney disease
Only approximately half of patients with chronic kidney disease and atrial fibrillation were treated with oral anticoagulants (OACs), and this proportion decreased significantly as kidney disease became more severe.
ACC 2019: Benefits and drawbacks of high-sensitivity troponin use in low-risk patients with chest pain
High-sensitivity troponin, an assay that is relatively new in the U.S., allows providers to assess low-risk chest pain patients more quickly and determine whether they have had a heart attack or myocardial infarction.
Few treatment guidelines for heart disease are based on rigorous study
More than 90 percent of heart care recommendations are supported by lower-quality evidence, a new study finds.
Catheter ablation more effective at correcting atrial fibrillation
The CABANA trial found the procedure improved patients’ symptoms and quality of life.
DCRI faculty member recognized by American Gastroenterological Association
The DCRI’s David Leiman, MD, MSHP was selected as one of 18 participants in this year’s AGA Future Leaders Program.
Duke University among top 10 in nation for federal medical research funding
The university ranked 9th in the United States among similar institutions.
Pediatric Trials Network studies lead to FDA approval of acyclovir labeling supplement
The antiviral drug’s label will now include dosing information for infants, drawing on results from two pediatric studies led by DCRI investigators.
Patient-generated data come with opportunities, challenges
The DCRI’s Satasuk Joy Bhosai, MD, MPH, recently discussed the future of data-driven care.
Gene therapy trial for Pompe disease begins
Researchers, including the DCRI’s Priya Kishnani, MD, hope the study will provide more treatment options for patients with the disease.